Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice

International Journal of Obesity

Volumn 36, Issue 2, 2012, Pages 244-253

  Csongradi, E ^a,b   Docarmo, J M ^a   Dubinion, J H ^a   Vera, T ^a   Stec, D E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

adiponectin; diabetes; gene knockout; heme oxygenase; leptin; metabolism

Indexed keywords

ADIPONECTIN; CARBON DIOXIDE; GLUCOSE; HEME OXYGENASE 1; INSULIN; MELANOCORTIN 4 RECEPTOR; PROTOPORPHYRIN COBALT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT DISTRIBUTION; BODY TEMPERATURE; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIVER METABOLISM; MALE; METABOLISM; MOUSE; MUSCLE METABOLISM; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RESPIRATORY QUOTIENT; THERMOGENESIS; WEIGHT REDUCTION;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; HEME OXYGENASE-1; MALE; MICE; MICE, OBESE; MOTOR ACTIVITY; OXYGEN CONSUMPTION; PROTOPORPHYRINS; RECEPTOR, MELANOCORTIN, TYPE 4; THERMOGENESIS; WEIGHT LOSS;

MUS; RODENTIA;

EID: 84857048733     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.78     Document Type: Article

References (40)

1. Galbraith RA, Kappas A. Regulation of food intake and body weight by cobalt porphyrins in animals. Proc Natl Acad Sci USA 1989; 86: 7653-7657. (Pubitemid 19254513)
2. Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, Ikehara S et al. L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice. J Lipid Res 2008; 49: 1658-1669.
3. Peterson SJ, Kim DH, Li M, Positano V, Vanella L, Rodella LF et al. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice. J Lipid Res 2009; 50: 1293-1304.
4. Galbraith RA, Kappas A. Intracerebroventricular administration of cobalt protoporphyrin elicits prolonged weight reduction in rats. Am J Physiol 1991; 261 (Part 2): R1395-R1401.
5. Galbraith RA, Kow LM, Pfaff D, Kappas A. Injection of cobalt protoporphyrin into the medial nuclei of the hypothalamus elicits weight loss. Am J Physiol 1992; 263 (Part 2): R805-R812.
6. Galbraith RA, Chua Jr. SC, Kappas A. Hypothalamic mechanism for cobalt protoporphyrin-induced hypophagia and weight loss: Inhibition of the feeding response to NPY. Brain Res Mol Brain Res 1992; 15: 298-302.
7. Turner MB, Corp ES, Galbraith RA. Lack of NPY-induced feeding in cobalt protoporphyrin-treated rats is a postreceptor defect. Physiol Behav 1994; 56: 1009-1014. (Pubitemid 24337118)
8. Li M, Vizzard MA, Jaworski DM, Galbraith RA. The weight loss elicited by cobalt protoporphyrin is related to decreased activity of nitric oxide synthase in the hypothalamus. J Appl Physiol 2006; 100: 1983-1991. (Pubitemid 43845874)
9. Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S et al. Obesity-induced hypertension: Role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem 2010; 285: 17271-17276.
10. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141. (Pubitemid 27180337)
11. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005; 123: 493-505. (Pubitemid 41546678)
12. Ste ML, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 2000; 97: 12339-12344.
13. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998; 20: 113-114. (Pubitemid 28455439)
14. Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, ORahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998; 20: 111-112. (Pubitemid 28455438)
15. Ma L, Tataranni PA, Bogardus C, Baier LJ. Melanocortin 4 receptor gene variation is associated with severe obesity in Pima Indians. Diabetes 2004; 53: 2696-2699. (Pubitemid 39299281)
16. Butler AA, Kozak LP. A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 2010; 59: 323-329.
17. Converso DP, Taille C, Carreras MC, Jaitovich A, Poderoso JJ, Boczkowski J. HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. FASEB J 2006; 20: 1236-1238.
18. Slebos DJ, Ryter SW, van der Toorn M, Liu F, Guo F, Baty CJ et al. Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am J Respir Cell Mol Biol 2007; 36: 409-417. (Pubitemid 46622998)
19. Di Noia MA, Van Driesche S, Palmieri F, Yang LM, Quan S, Goodman AI et al. Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes. J Biol Chem 2006; 281: 15687-15693. (Pubitemid 43848455)
20. Suliman HB, Carraway MS, Ali AS, Reynolds CM, Welty-Wolf KE, Piantadosi CA. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest 2007; 117: 3730-3741. (Pubitemid 350224084)
21. Piantadosi CA, Carraway MS, Babiker A, Suliman HB. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 2008; 103: 1232-1240.
22. Rhodes MA, Carraway MS, Piantadosi CA, Reynolds CM, Cherry AD, Wester TE et al. Carbon monoxide, skeletal muscle oxidative stress, and mitochondrial biogenesis in humans. Am J Physiol Heart Circ Physiol 2009; 297: H392-H399.
23. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008; 57: 1526-1535.
24. Ignarro LJ, Degnan JN, Baricos WH, Kadowitz PJ, Wolin MS. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim Biophys Acta 1982; 718: 49-59.
25. Makino R, Matsuda H, Obayashi E, Shiro Y, Iizuka T, Hori H. EPR characterization of axial bond in metal center of native and cobalt-substituted guanylate cyclase. J Biol Chem 1999; 274: 7714-7723.
26. Ndisang JF, Jadhav A. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension. J Pharmacol Exp Ther 2010; 334: 87-98.
27. Nicolai A, Li M, Kim DH, Peterson SJ, Vanella L, Positano V et al. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension 2009; 53: 508-515.
28. Ewing JF, Haber SN, Maines MD. Normal and heat-induced patterns of expression of heme oxygenase-1 (HSP32) in rat brain: Hyperthermia causes rapid induction of mRNA and protein. J Neurochem 1992; 58: 1140-1149.
29. Rodella L, Lamon BD, Rezzani R, Sangras B, Goodman AI, Falck JR et al. Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes. Free Radic Biol Med 2006; 40: 2198-2205. (Pubitemid 43903106)
30. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 2005; 289: H701-H707. (Pubitemid 41129386)
31. Ndisang JF, Jadhav A. Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology 2009; 150: 2627-2636.
32. Ndisang JF, Lane N, Jadhav A. The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways. Endocrinology 2009; 150: 2098-2108.
33. Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 2006; 48: 58-64. (Pubitemid 44297525)
34. Zhou L, Williams T, Lachey JL, Kishi T, Cowley MA, Heisler LK. Serotonergic pathways converge upon central melanocortin systems to regulate energy balance. Peptides 2005; 26: 1728-1732. (Pubitemid 41354530)
35. Lam DD, Przydzial MJ, Ridley SH, Yeo GS, Rochford JJ, O'Rahilly S et al. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 2008; 149: 1323-1328. (Pubitemid 351397929)
36. Chen AS, Metzger JM, Trumbauer ME, Guan XM, Yu H, Frazier EG et al. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res 2000; 9: 145-154. (Pubitemid 30610232)
37. Cepoi D, Phillips T, Cismowski M, Goodfellow VS, Ling N, Cone RD et al. Assessment of a small molecule melanocortin-4 receptor-specific agonist on energy homeostasis. Brain Res 2004; 1000: 64-71. (Pubitemid 38446490)
38. Markison S, Foster AC, Chen C, Brookhart GB, Hesse A, Hoare SR et al. The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonist. Endocrinology 2005; 146: 2766-2773. (Pubitemid 40695581)
39. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000; 141: 3518-3521. (Pubitemid 32269044)
40. Butler AA, Cone RD. Knockout studies defining different roles for melanocortin receptors in energy homeostasis. Ann NY Acad Sci 2003; 994: 240-245. (Pubitemid 36793873)